While downregulation of TRIM47 lowered the expression levels of β-catenin, c-MYC, and cyclin D1, exogenous activation of Wnt/β-catenin signaling (Figure 2a) abolished the previous effects of TRIM47 knockdown observed in glioma cells [90]. This evidence concerns the gene TRIM47 and central nervous system cancer.